108 related articles for article (PubMed ID: 9406573)
1. Sublocalization of the breakpoints of a t(5;16) in myelodysplasia.
van Soest RA; Bolk MW; Kluck PM; Janssen B; van Kessel AG; Wessels HW; Willemze R; Landegent JE
Cancer Genet Cytogenet; 1998 Jan; 100(1):5-9. PubMed ID: 9406573
[TBL] [Abstract][Full Text] [Related]
2. Sublocalization of the chromosome 5 breakpoint of the 3;5 translocation in myelodysplastic syndromes and acute myeloid leukemia.
Morris SW; Foust JT; Valentine MB; Roberts WM; Shapiro DN; Look AT
Genes Chromosomes Cancer; 1992 Nov; 5(4):385-91. PubMed ID: 1283327
[TBL] [Abstract][Full Text] [Related]
3. der(3)t(3;5). Another recurring abnormality in myelodysplastic disorder.
Lindgren V; Gibson L; Yang-Feng TL
Cancer Genet Cytogenet; 1991 Jul; 54(1):129-31. PubMed ID: 2065307
[TBL] [Abstract][Full Text] [Related]
4. Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome.
Hoffman MW; Janney S; Batanian JR
Cancer Genet Cytogenet; 2009 Jun; 191(2):106-8. PubMed ID: 19446747
[TBL] [Abstract][Full Text] [Related]
5. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
6. A case of myelodysplasia with eosinophilia having a translocation t(5;12) (q31;q13) restricted to myeloid cells but not involving eosinophils.
Jani K; Kempski HM; Reeves BR
Br J Haematol; 1994 May; 87(1):57-60. PubMed ID: 7947256
[TBL] [Abstract][Full Text] [Related]
7. Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.
Yamamoto K; Nagata K; Yagasaki F; Tsurukubo Y; Tamura A; Taniwaki M; Hamaguchi H
Cancer Genet Cytogenet; 2000 Jun; 119(2):113-7. PubMed ID: 10867145
[TBL] [Abstract][Full Text] [Related]
8. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
9. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
[TBL] [Abstract][Full Text] [Related]
10. Two karyotypically unrelated clones with the t(5;17) and deletion of 5q in myelodysplastic syndrome.
Novak A; Jankovic G; Rolovic Z
Cancer Genet Cytogenet; 1992 Aug; 62(1):100-2. PubMed ID: 1521224
[TBL] [Abstract][Full Text] [Related]
11. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements.
Berger R; Busson M; Baranger L; Hélias C; Lessard M; Dastugue N; Speleman F
Leukemia; 2006 Feb; 20(2):319-21. PubMed ID: 16341035
[TBL] [Abstract][Full Text] [Related]
12. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.
Royer-Pokora B; Trost D; Müller N; Hildebrandt B; Germing U; Beier M
Cancer Genet Cytogenet; 2006 May; 167(1):66-9. PubMed ID: 16682289
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, breakpoint distribution, and clinical correlates of t(5;12).
Greipp PT; Dewald GW; Tefferi A
Cancer Genet Cytogenet; 2004 Sep; 153(2):170-2. PubMed ID: 15350308
[TBL] [Abstract][Full Text] [Related]
14. Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.
Lunghi M; Casorzo L; De Paoli L; Riccomagno P; Rossi D; Gaidano G
Cancer Genet Cytogenet; 2010 Jan; 196(1):89-92. PubMed ID: 19963141
[TBL] [Abstract][Full Text] [Related]
15. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.
Bram S; Swolin B; Rödjer S; Stockelberg D; Ogärd I; Bäck H
Cancer Genet Cytogenet; 2003 Apr; 142(2):107-14. PubMed ID: 12699885
[TBL] [Abstract][Full Text] [Related]
16. Unbalanced 1q whole-arm translocation resulting in der(14)t(1;14)(q11-12;p11) in myelodysplastic syndrome.
Fogu G; Campus PM; Cambosu F; Moro MA; Sanna R; Fozza C; Nieddu RM; Longinotti M; Montella A
Cytogenet Genome Res; 2012; 136(4):256-63. PubMed ID: 22571950
[TBL] [Abstract][Full Text] [Related]
17. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
19. Clinical and experimental study of two cases of myelodysplastic syndrome with t(3; 5) (q25; q34) translocation.
Wu Y; Xue Y; Zhao M; Chen S; Pan J; Lu D
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):304-6. PubMed ID: 12411061
[TBL] [Abstract][Full Text] [Related]
20. KRAS2 oncogene overexpression in myelodysplastic syndrome with translocation 5;12.
Srivastava A; Boswell HS; Heerema NA; Nahreini P; Lauer RC; Antony AC; Hoffman R; Tricot GJ
Cancer Genet Cytogenet; 1988 Oct; 35(1):61-71. PubMed ID: 3180012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
